Ringworm

Ringworm is also called tinea corporis. (Corporis is the Latin word for body.) The “ring” in ringworm is a red, circular rash that appears on the body. The rash has an area of clearer skin in the middle. Like other common tinea infections, it is caused by a fungus and not by a worm.

Only NAFTIN CREAM, 2% is indicated for the treatment of tinea corporis; NAFTIN GEL 2% is not indicated for this use.

Ringworm is highly contagious. You may get the infection through:

  • Direct skin-to-skin contact with someone who has it
  • Touching or petting an animal with ringworm (cats, dogs, farm animals)
  • Touching objects or surfaces that have been touched by a person or animal with ringworm
  • Contact with infected soil

Symptoms

  • Ringworm often begins as a flat, scaly patch on the skin
  • For some people, redness and itchiness may occur
  • A slightly raised border of skin develops and expands outward to form a ring
  • The shape of the ring may be irregular, like the wavy outline of a snake or a worm
  • Inside the ring, the skin may be clear, scaly, or have red bumps
  • For some people, several rings may appear at the same time and may overlap

QUICK TIP:

Do not share towels or clothing with others.

Learn more
ExpandCollapseClick to See Complete Safety InformationClose

INDICATIONS AND USAGE: NAFTIN (naftifine hydrochloride) GEL 2% is an allylamine antifungal indicated for the treatment of athlete’s foot between the toes caused by fungus in patients 12 years of age and older.

WARNING: If there is redness or irritation on the skin with the use of NAFTIN GEL 2%, stop treatment and speak with your doctor.

INFORMATION FOR PATIENTS:

1. NAFTIN GEL 2% is only for use on top of the skin. NAFTIN GEL 2% should not be used in the mouth, eyes, or vagina.

2. If there is irritation or redness with the use of NAFTIN GEL 2%, treatment should be stopped. Contact your doctor if you have irritation or redness on the skin after using NAFTIN GEL 2%.

Cancer Risk: It is not known whether NAFTIN causes cancer or causes a risk of cancer. Long-term studies to evaluate the risk of cancer from NAFTIN GEL 2% have not been done.

Pregnancy: Let your doctor know if you are pregnant or plan to become pregnant. NAFTIN GEL 2% should be used during pregnancy only if the benefit to the mother is greater than the risk to the unborn baby.

Nursing Mothers: It is not known whether this drug passes into breast milk. Because many drugs pass into breast milk, women who are nursing should take care when using NAFTIN GEL 2%.

Pediatric Use: Safety and effectiveness in children under 12 years old has not been proven.

SIDE EFFECTS: In clinical trials with NAFTIN GEL 2%, the most common side effect was itching on the skin where the medicine was applied.


You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088.

REFERENCES: 1. Vlahovic TC. Choosing the right vehicle. Podiatr Manage. June/July 2008;209-218. 2. Data on file, Sebela Pharmaceuticals.